Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005886-21Phase 2Completed
Phase 2 trial of ivabradine in chronic heart failure (CHF) and hypertension (HTN) (2 arms), sponsored by Servier. Primary endpoint: Change in systolic blood pressure. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005886-21.